Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 1

2(40.0%)

Phase 4

1(20.0%)

5Total

N/A(2)

Phase 1(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07183423Not ApplicableRecruiting

Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction

Role: lead

NCT05484960Unknown

The Philippine Neurological Association One Database -Dementia

Role: collaborator

NCT04386083Unknown

Neurologic Manifestations of COVID-19

Role: collaborator

NCT04077216Not ApplicableCompleted

Effect of Extra Virgin Olive Oil on Postprandial Blood Glucose in Type 2 Diabetes Mellitus Patients

Role: lead

NCT03113162Phase 1Unknown

Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis

Role: lead

NCT02241174Phase 1Withdrawn

0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitis

Role: lead

NCT01898182Phase 4Completed

Efficacy and Safety of Kinetin 0.1% for Treatment of Skin Photoaging

Role: lead

All 7 trials loaded